The Blog

Respiratory Syncytial Virus (RSV) Vaccine

Respiratory Syncytial Virus (RSV) Vaccine

Matt Crist

Concerned about getting Respiratory Syncytial Virus (RSV)?

Older adults are more likely to develop serious complications from a cold-like virus called Respiratory Syncytial Virus (RSV). Join a clinical trial to help us research an investigational study vaccine to prevent RSV disease.

To qualify, you must:
  • Be 60+ years old
Qualified participants will receive:
  • Study-related medical exams at no cost
  • Study-related medication at no cost
  • Compensation for time and travel
SEE IF YOU QUALIFY
 
 

What To Expect?

Three Easy Steps

Give us a call

Step 1
FILL OUT YOUR CONTACT INFORMATION OR GIVE US A CALL

A recruiter will reach out

Step 2
A RECRUITER WILL REACH OUT SHORTLY AND ASK YOU SOME QUESTIONS

Schedule a visit

Step 3
IF YOU’RE QUALIFIED, YOU WILL BE SCHEDULED FOR AN OFFICE VISIT
About

Wake Research is an integrated organization of premier investigational sites working closely with and meeting the needs of the biopharmaceutical, biotechnology, medical device, pharmaceutical industry and clinical research organizations in North America.